Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 Mar 2024 – 20 Aug 2026, limited by Edelweiss Technology Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Edelweiss Technology Fund | Nifty 500 |
|---|---|---|
| 07 Mar 2024 | ₹100.00 | ₹100.00 |
| 21 May 2024 | ₹99.99 | ₹103.68 |
| 03 Aug 2024 | ₹113.19 | ₹113.82 |
| 17 Oct 2024 | ₹121.78 | ₹114.40 |
| 31 Dec 2024 | ₹123.69 | ₹109.50 |
| 15 Mar 2025 | ₹102.74 | ₹98.73 |
| 29 May 2025 | ₹114.21 | ₹111.87 |
| 12 Aug 2025 | ₹118.38 | ₹110.44 |
| 25 Oct 2025 | ₹124.32 | ₹115.91 |
| 08 Jan 2026 | ₹124.93 | ₹115.88 |
| 24 Mar 2026 | ₹109.02 | ₹103.09 |
| 06 Jun 2026 | ₹121.51 | ₹109.94 |
| 20 Aug 2026 | ₹132.68 | ₹115.06 |
| Metric | Edelweiss · Direct NAV ₹13.32 Very High risk ★★★★☆ 1Y | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +11.14% | +7.23% | |
| — | +16.94% | |
| — | +14.70% | |
| — | +15.10% | |
| +12.22% | +14.07% | |
| +11.63% | — | |
| — | +17.59% | |
| — | +16.29% | |
| — | +16.00% | |
| Risk | ||
| 15.03% | 15.69% | |
| 0.31 | 0.52 | |
| 0.43 | 0.73 | |
| -26.24% | -23.08% | |
| Nifty 500 | — | |
| — | +4.66% | |
| — | 0.96 | |
| — | 109.1% | |
| — | 91.0% | |
| 0.81% | 1.14% | |
| ₹700.63Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 4% | 45% | |
| Amit Vora | — | |
| 07 Mar 2024 | — | |
| 29 | — | |
| 47.7% | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.